David Kuter, Chen Yunfei, Nicola Cooper, Waleed Ghanima, Hisashi Kato, Yoshiaki Tomiyama, Raymond Wong, Renchi Yang, Cheryl Li, Emily Skelton, Scarlett Wang, Donald Yee, Parth Patwari. "Trial in progress: Study design of a randomized, phase 3 trial evaluating the efficacy and safety of mezagitamab (TAK-079) compared with placebo in adults with chronic primary immune thrombocytopenia." Blood (2025). https://doi.org/10.1182/blood-2025-3049